FDA launches new priority review voucher program for select biopharmas

Bharat Biotech

pass the torch deal sell buy acquisition
Biotech

GSK offloads shigella vaccine to Bharat ahead of phase 3

GSK framed the deal as a way to get the vaccine to patients in low- and middle-income countries where the pathogen is a health threat.
Nick Paul Taylor Jun 12, 2025 9:18am